[Effect of papaverine and cholinolytics on the function of the hepatobiliary system in patients with cholecystitis associated with chronic ischemic heart disease].
Kushnir
V E
VE
Novopashennaia
V V
VV
Sidorova
L L
LL
Kuklia
Iu I
IuI
D000328:Adult; D000368:Aged; D002764:Cholecystitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D005704:Gallbladder / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010276:Parasympatholytics / Q000008:administration & dosage*
D010276:Parasympatholytics; D010208:Papaverine
Vliianie papaverina i kholinilitikov na funktsii gepatobiliarnoĭ sistemy u bol'nykh kholetsistitom v sochetanii s khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.